Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we will assume that you are happy to receive all cookies and you will not see this message again. Click 'Find out more' for information on how to change your cookie settings.

Our Researchers at the Oxford Parkinson’s Disease Centre have shown that cell recycling in Parkinson’s may play a more complex role than previously thought.

A team including researchers from the Cragg and Wade-Martins Groups in the OPDC have shown that cell recycling in Parkinson’s may play a more complex role than previously thought.

These new results have been published in Cell Reports in a paper entitled "Impairment of Macroautophagy in Dopamine Neurons Has Opposing Effects on Parkinsonian Pathology and Behavior."

Read the full story on the Parkinson's UK website.

 

Research team:

Benjamin H.M.Hunn

Peter Oliver

Siv Vingill

Sarah Threlfell

Javier Alegre-Abarrategui

Morgane Magdelyns

Thierry Deltheil

Nora Bengoa-Vergniory

Milena Cioroch

Natalie M.Doig

Stephanie Cragg

Richard Wade-Martins

Similar stories

Winners of the DPAG Student Poster Day 2021 announced

"A Year of Progress" was held in the Sherrington Library and Sherrington PCR Café on Thursday 18 November 2021.

Oxford-led research maps milestone stage of human development for the first time

Scientists have shed light on an important stage of early embryonic development that has never been fully mapped out in humans before.

Wade-Martins Group achieves Bronze award for sustainable practices

The Wade-Martins Group has achieved a Laboratory Efficiency Assessment Framework (LEAF) Bronze award in recognition of its sustainable practices.

Mapping uncharted networks in the progression of Parkinson’s

A major new $9 million project funded by the Aligning Science Across Parkinson’s (ASAP) initiative will map the original circuits vulnerable to Parkinson’s on an unprecedented scale. The project is a collaboration between core investigators Stephanie Cragg, Richard Wade-Martins, and Peter Magill at Oxford, Mark Howe at Boston University and Dinos Meletis at the Karolinska Institutet, as well as collaborators Yulong Li at Peking University and Michael Lin at Stanford University.

Drug could help diabetic hearts recover after a heart attack

New research led by Associate Professor Lisa Heather has found that a drug known as molidustat, currently in clinical trials for another condition, could reduce risk of heart failure after heart attacks.